The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation
Open accessAbstract
BACKGROUND AND OBJECTIVES: The treatment of acquired aplastic anemia (AA) is based on allogeneic bone marrow transplantation (BMT) and immunosuppressive therapy. The aim of this study was to assess the outcome of children and adults with AA treated in the last decade, and to determine whether results have improved in two sequential time periods,1991-1996 and 1997-2002. DESIGN AND METHODS: Two-thousands and seventy-nine consecutive patients with AA, classified according to first-line treatment: BMT (n=1567) or immunosuppressive therapy (n= 912), the patients for the two sequential time periods were studied. Analyses included variables related to patients, disease and transplant. RESULTS: The actuarial 10-year survival was 73% and 68% for BMT or immunosuppressive treatment, respectively (p=0.002). BMT outcome improved significantly with time (69% and 77%, p=001) for both matched sibling donor (MSD) (74% and 80%; p=0.003 ), alternative donor (38% and 65% p=0.0001), and was better in children (79% versus 68%, p<0.0001). Multivariate analysis: favorable predictors (p<0.001) were younger age, transplant beyond 1996, MSD, a short interval diagnosis-transplant , no irradiation. IS: no significant improvement over time (69% and 73% p=0.29). Survival was significantly better in children (81% versus 70%, p=0.001), especially in vSAA(83% versus 62%, p=0.0002). Combined IS was superior to single drug treatment (77% versus 62%, p=0.002). Multivariate analysis: significant predictors of survival: age > or =16 years (p=0.0009), longer interval between diagnosis -treatment (p=0.04), single drug versus combined IS (p=0.02). INTERPRETATION AND CONCLUSIONS: Outcome has improved in subsets of AA patients: those receiving first- line BMT and children with vSAA treated with IS. Age remains a major predictor for both treatments. Early intervention is associated with a significantly better outcome and is strongly recommended, whatever the first-line therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malignant Tumors Occurring after Treatment of Aplastic Anemia
Socié, G., Henry-Amar, M., Bacigalupo, A. P., Hows, J., Tichelli, A., Ljungman, P. T., McCann, S. R., Frickhofen, N., Veer-Korthof, E. T. V., & Gluckman, É. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310143291603 · Cited by 458
Self-citationNonmalignant late effects after allogeneic stem cell transplantation
Socie, G. (2003) · Blood · doi:10.1182/blood-2002-07-2231 · Cited by 425
Self-citationFrickhofen, N., Heimpel, H., Kaltwasser, J. P., & Schrezenmeier, H. (2003) · Blood · doi:10.1182/blood-2002-04-1134 · Cited by 330
Self-citationBacigalupo, A. P., Brand, R., Oneto, R., Bruno, B., Sodé, G., Passweg, J. R., Locasciulli, A., Lint, M. T. V., Tichelli, A., McCann, S., et al. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90031-3 · Cited by 272
Self-citationSchmitz, N. (2002) · Blood · doi:10.1182/blood-2001-12-0304 · Cited by 271
Bacigalupo, A. P., Bruno, B., Saracco, P., Bona, E. D., Locasciulli, A., Locatelli, F., Gabbas, A., Dufour, C., Arcese, W., Testi, G., et al. (2000) · Blood · doi:10.1182/blood.v95.6.1931 · Cited by 269
Self-citationKojima, S., Hibi, S., Kosaka, Y., Yamamoto, M., Tsuchida, M., Mugishima, H., Sugita, K., Yabe, H., Ohara, A., & Tsukimoto, I. (2000) · Blood · doi:10.1182/blood.v96.6.2049 · Cited by 253
Long-term outcome after bone marrow transplantation for severe aplastic anemia
Ades, L., Mary, J.-Y., Robin, M., Ferry, C., Porcher, R., Esperou, H., Ribaud, P., Devergie, A., Traineau, R., Gluckman, E., et al. (2004) · Blood · doi:10.1182/blood-2003-07-2546 · Cited by 207
Self-citationLong-Term Outcome After Marrow Transplantation for Severe Aplastic Anemia
Deeg, H. J., Leisenring, W. M., Storb, R. F., Nims, J. W., Flowers, M. E. D., Witherspoon, R. P., Sanders, J. E., & Sullivan, K. M. (1998) · Blood · doi:10.1182/blood.v91.10.3637 · Cited by 202
Bacigalupo, A. P., Locatelli, F., Lanino, E., Marsh, J. C. W., Socié, G., Maury, S., Prete, A., Locasciulli, A., Cesaro, S., Passweg, J. R., et al. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705165 · Cited by 185
Self-citation
Cited by
Guidelines for the diagnosis and management of aplastic anaemia
Marsh, J. C. W., Ball, S. E., Cavenagh, J., Darbyshire, P., Dokal, I., Gordon‐Smith, E. C., Keidan, J., Laurie, A., Martin, A., Mercieca, J., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07842.x · Cited by 560
How I treat acquired aplastic anemia
Bacigalupo, A. (2017) · Blood · doi:10.1182/blood-2016-08-693481 · Cited by 421
Self-citationSakaguchi, H., Nishio, N., Hama, A., Kawashima, N., Wang, X., Narita, A., Doisaki, S., Xu, Y., Muramatsu, H., Yoshida, N., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.091165 · Cited by 47
Metadata
- Authors
- Locasciulli, A., Oneto, R., Bacigalupo, A., Socie, G., Korthof, E., Bekassy, A., Schrezenmeier, H., Passweg, J., Fuhrer, M., & on the behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (SAA-WP, B.
- Venue
- Haematologica
- Published
- 2007-01-01
- Volume
- 92
- Issue
- 1
- Pages
- 11-18
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2018493712
- Cited by
- 330
- References
- 19
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation. https://app.cochat.ai/papers/10.3324/haematol.10075
- The paper
- Locasciulli, A., Oneto, R., Bacigalupo, A., Socie, G., Korthof, E., Bekassy, A., Schrezenmeier, H., Passweg, J., Fuhrer, M., & on the behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (SAA-WP, B. (2007). Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation. Haematologica. https://doi.org/10.3324/haematol.10075
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.